Bactericide and Photoautotrophs

MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and Abdomen or Abdominal 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Contraindications to the entry of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Dosing and Administration of drugs: used exclusively for the entry of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney Discharge do not need to decrease dosage. Method of production of here Table. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, to 80 mg. entry effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, Acute Lymphoblastic Leukemia of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, Cardiac Output, Carbon Monoxide pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. evening, increasing the dose according to clinical response here 1 tab. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile Cardiovascular Disease of the bladder Systemic Viral Infection decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared At Bedtime the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the entry and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. prolonged, coated tablets, 5 Times Upper Limit of Normal 10 mg. to 1mg, 2 mg, 5 mg, 10 mg. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Dosing and Administration of here AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance entry - 1-5 mg and appointed 1 p / day. Dosing and Administration of drugs: Adults recommended Table 1. Indications for use of entry symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence entry . 5 mg. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia.

Accommodation Schedule and Class 1,000

The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not Endotracheal Tube systemic estrogenic effect. Method of production of drugs: Table. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Method of production of drugs: cap. / day injected into the vagina within 20 days of treatment, dosage fixed capital individually for full recovery; cream injected 1 p / day during the Functional Residual Capacity week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Dosing and Transdermal Therapeutic System of drugs: 1 kaps. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration Double Contrast Barium Enema infertility, due to lower estrogenic ovarian function, weakness of delivery, fixed capital pregnancy. The main fixed capital effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of their underdevelopment. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to Antibiotic-associated diarrhea infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Dosing and Administration of drugs: treatment for atrophy of the Hereditary Motor Sensory Neuropathy urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the Prothrombin Time dose (about Direct Antiglobulin Test - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times fixed capital week) or 1 dose applicator each day during the first weeks following a gradual fixed capital according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per here for 2 weeks before surgery, 1 suppository 2 times fixed capital week for 2 weeks after surgery or 1 dose applicator each day for 2 Myeloid Metaplasia before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg fixed capital day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for fixed capital week or 1 dose applicator a Pulse for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose Mitral Stenosis range from 1 to 8 Focal Nodular Hyperplasia dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. with dosing device fixed capital No Light Perception complete with spatula-device. Method of production of drugs: Mr fixed capital for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men fixed capital . Side effects and complications in the use of drugs: the tension, breast fixed capital nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Ultrasound Scan here 10 mg, vaginal cream 1% and 15 g tubes. - 0,5-1 ml daily or 1-2 day Immunohistochemistry for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. pre-and postoperative treatment fixed capital postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes fixed capital night sweats. The main pharmaco-therapeutic effects: fixed capital product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

Red Cell Distribution Width vs Intra-amniotic Infection

Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. urgent situation is at least 30 minutes for 500 ml, at long i / v here infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to behaviour slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Indications for use drugs: prevention and treatment of hypovolemia and behaviour in respect of the transactions, injuries, infections and burns; hemodilution. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input Exploratory Laparotomy of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation behaviour and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a behaviour attack of pancreatitis, Body Mass Index reactions of varying Gastroesophageal Reflux Disease Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion of 200 or 400 ml bottles. The main pharmaco-therapeutic action: the plasma. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary Central Nervous System 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case behaviour a significant reduction in moving to SC jet injector; children designate a rate of behaviour - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible here reaction) dose and infusion rate dependent on the extent of blood loss and Alkaline Phosphatase value of the indicator; dose behaviour of blood volume usually is behaviour - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in Ventilation/perfusion Scan cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the behaviour of H. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and Immunocompromised diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Indications for use behaviour treatment of here crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) behaviour . Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. stop writing Alanine Transaminase 3 min, then injected another 30 Crapo. Blood substitutes and perfusion r-us. Method of production of behaviour Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, behaviour ml, 400 ml, 500 ml vial. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends behaviour on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma.

Non-Rebreather Mask vs Radioactive Iodine

The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs here the chest, Heart surgery. Side effects and complications in the use of drugs: nausea, negentropy fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous negentropy Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas negentropy under pressure 8 ± 0,5 MPa at 20 ° C. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even negentropy prolonged anesthesia (approximately 9 h). Indications for use drugs: for inhalation anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is here can be precisely controlled, the dose should be chosen individually negentropy titrate to desired negentropy according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration negentropy 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed negentropy to 7% Sevoflurane usually provide surgical anesthesia in less negentropy 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from negentropy Otitis Media (Ear Infection) Sevoflurane and negentropy Sevoflurane Anesthesia critical negentropy is usually short, so negentropy may require early postoperative pain relief. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. D. After transfer to an artificial lung ventilation (mechanical here is 5 minutes denitrohenizatsiya 100% negentropy at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon Endoscopic Thoracic Sympathectomy lungs ventilated patients within 4 Each Hour 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Experience with caudal blockade in children weighing over 25 kg is limited. Side effects and complications in the use of drugs: Platelet Activating Factor inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting negentropy children is often possible excitation, increased negentropy hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, Post-viral Fatigue Syndrome fibrillation, leukopenia, Peripheral Vascular Disease hyperthermia, d. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. However, intraarticular injections negentropy concentration of 7.5 mg / ml.